189 related articles for article (PubMed ID: 19954554)
1. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.
Merle U; Sieg O; Stremmel W; Encke J; Eisenbach C
BMC Gastroenterol; 2009 Dec; 9():91. PubMed ID: 19954554
[TBL] [Abstract][Full Text] [Related]
2. Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure.
Quintero J; Miserachs M; Ortega J; Bueno J; Dopazo C; Bilbao I; Castells L; Charco R
Liver Int; 2014 May; 34(5):689-94. PubMed ID: 24112412
[TBL] [Abstract][Full Text] [Related]
3. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients.
Reekers M; Simon MJ; Boer F; Mooren RA; van Kleef JW; Dahan A; Vuyk J
Anesth Analg; 2010 Feb; 110(2):466-72. PubMed ID: 20081133
[TBL] [Abstract][Full Text] [Related]
4. Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients.
Sakka SG
J Clin Monit Comput; 2018 Oct; 32(5):787-796. PubMed ID: 29039062
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure.
Feng HL; Li Q; Wang L; Yuan GY; Cao WK
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):271-5. PubMed ID: 24919610
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
Inal MT; Memiş D; Kargi M; Sut N
J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
[TBL] [Abstract][Full Text] [Related]
8. Indocyanine green disappearance rate is the most useful marker for liver resection.
Scheingraber S; Richter S; Igna D; Flesch S; Kopp B; Schilling MK
Hepatogastroenterology; 2008; 55(85):1394-9. PubMed ID: 18795697
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation.
Schneider L; Spiegel M; Latanowicz S; Weigand MA; Schmidt J; Werner J; Stremmel W; Eisenbach C
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):362-8. PubMed ID: 21813383
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.
Sakka SG; Reinhart K; Meier-Hellmann A
Chest; 2002 Nov; 122(5):1715-20. PubMed ID: 12426276
[TBL] [Abstract][Full Text] [Related]
11. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ
Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838
[TBL] [Abstract][Full Text] [Related]
12. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
Escorsell À; Mas A; Fernández J; García-Valdecasas JC
Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
[TBL] [Abstract][Full Text] [Related]
13. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients.
Halle BM; Poulsen TD; Pedersen HP
Acta Anaesthesiol Scand; 2014 Nov; 58(10):1214-9. PubMed ID: 25307706
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
Scheingraber S; Richter S; Igna D; Girndt M; Flesch S; Kleinschmidt S; Schilling MK
Clin Transplant; 2007; 21(6):689-95. PubMed ID: 17988260
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine green clearance as an outcome prediction tool in cardiac surgery: a prospective study.
Weis F; Kilger E; Beiras-Fernandez A; Hinske CL; Nassau K; Adnan L; Vicol C; Kur F; Möhnle P
J Crit Care; 2014 Apr; 29(2):224-9. PubMed ID: 24332990
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of ICG-PDR in patients with hypoxic hepatitis.
Horvatits T; Kneidinger N; Drolz A; Roedl K; Rutter K; Kluge S; Trauner M; Fuhrmann V
Ann Intensive Care; 2015 Dec; 5(1):47. PubMed ID: 26637474
[TBL] [Abstract][Full Text] [Related]
18. Liver function assessment using indocyanine green plasma disappearance rate in a young male with icteric leptospirosis: a case report.
Kunikowska AJ; Wildgruber M; Schulte-Frohlinde E; Lahmer T; Schmid RM; Huber W
BMC Infect Dis; 2019 May; 19(1):473. PubMed ID: 31138261
[TBL] [Abstract][Full Text] [Related]
19. Liver function assessment by indocyanine green plasma disappearance rate in patients with intra-abdominal hypertension after "non-hepatic" abdominal surgery.
Kovac N; Peric M
Curr Med Res Opin; 2018 Oct; 34(10):1741-1746. PubMed ID: 29388442
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.
Thomas MN; Weninger E; Angele M; Bösch F; Pratschke S; Andrassy J; Rentsch M; Stangl M; Hartwig W; Werner J; Guba M
HPB (Oxford); 2015 Jun; 17(6):471-6. PubMed ID: 25581073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
